Clinical Trial Update: Safety Study of 2DG With Stereotactic Radiosurgery [Phase 1]

View source ↗

Summary

A Phase 1 safety study of 2-Deoxy-D-glucose with stereotactic radiosurgery for intracranial neoplasms and brain metastases has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Intracranial Neoplasms

Drugs mentioned

• 2-Deoxy-D-glucose (2-Deoxy-D-glucose)

Snippet

Sponsor: University of Iowa | Conditions: Intracranial Neoplasms, Neoplasm Metastasis | Phase 1 | Status: WITHDRAWN